Analysis of dendritic cell populations using a revised histological staging of morphoea
- 24 December 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 143 (6) , 1183-1192
- https://doi.org/10.1046/j.1365-2133.2000.03886.x
Abstract
Background Recent studies have suggested that dermal dendritic cells (DDCs) may play a part in maintaining the structure of the dermis and in dermal immune modulation. Alteration in the population of DDCs has been noted in localized and systemic scleroderma, particularly a decline in the number of CD34+ DDCs. Objectives To define the alteration of the DDC populations with respect to the histological stage of morphoea. Methods We examined 33 biopsies of morphoea, categorized into four histological stages, and examined the DDC population (CD34+ DDCs and factor XIIIa+ DDCs), the lymphocytic infiltrate, and tenascin (extracellular matrix glycoprotein) and transforming growth factor (TGF)‐β1 expression in each biopsy. Results As the dermis became less inflammatory and more sclerotic, there was a significant decline in the number of CD34+ DDCs and an increase in the number of factor XIIIa+ DDCs. The pan‐T‐cell infiltrate (UCHL‐1/CD45RO) and tenascin deposition exhibited a similar pattern, with elevated expression in inflammatory stages and a decrease in expression as the dermis became sclerotic. TGF‐β1 was significantly elevated in three of the four histological stages of morphoea, in both the inflammatory and sclerotic stages. The proposed four‐stage histological analysis of morphoea biopsies was a useful basis for studying dendritic cells and mediators in cutaneous sclerosis. Conclusions Our study indicates that there is a reciprocal relationship between CD34+ DDCs and factor XIIIa+ DDCs in morphoea that correlates with the relative degrees of inflammation and sclerosis.Keywords
This publication has 27 references indexed in Scilit:
- Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.Journal of Clinical Investigation, 1996
- Decreased Expression of the Human Progenitor Cell Antigen (CD34) in MorpheaThe American Journal of Dermatopathology, 1995
- Immunocytochemical Localization and Serologic Detection of Transforming Growth Factor β1Arthritis & Rheumatism, 1994
- A Study of Factor XHIa and MAC 387 Immunolabeling in Normal and Pathological SkinThe American Journal of Dermatopathology, 1990
- In vitro identification of a subpopulation of fibroblasts that produces high levels of collagen in scleroderma patientsArthritis & Rheumatism, 1990
- Evaluation of Transforming Growth Factor β and Type I Procollagen Gene Expression in Fibrotic Skin Disease by In Situ HybridizationJournal of Investigative Dermatology, 1990
- Characterization of factor XIIIa positive dermal dendritic cells in normal and inflamed skinBritish Journal of Dermatology, 1989
- Identification of Fibroblasts Responsible for Increased Collagen Production in Localized Scleroderma by In Situ HybridizationJournal of Investigative Dermatology, 1988
- Cellular infiltrates in scleroderma skinArthritis & Rheumatism, 1977
- Generalized MorpheaArchives of Dermatology, 1972